OOIR: Observatory of International Research

Papers

(The median citation count of Biosocieties is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Rethinking value construction in biomedicine and healthcare	15
The emergence of multimorbidity as a matter of concern: a critical review	10
Life’s continuation: repro-tech, biogenetic affinity, and racial capitalism	9
‘We thank you for your sacrifice’: Clinical vulnerability, shielding and biosociality in the UK’s Covid-19 response	9
‘The good economy’: a conceptual and empirical move for investigating how economies and versions of the good are entangled	7
Making valuable health: pharmaceuticals, global capital and alternative political economies	7
Reprowebs: a conceptual approach to elasticity and change in the global assisted reproduction industry	7
“The elephant in the room”: social responsibility in the production of sociogenomics research	6
Psychedelic innovations and the crisis of psychopharmacology	6
To wish you well: the biopolitical subjectivities of medical crowdfunders during and after Aotearoa New Zealand’s COVID-19 lockdown	6
The FDA’s standard-making process for medical digital health technologies: co-producing technological and organizational innovation	6
Value-creation in the health data domain: a typology of what health data help us do	6
Beyond the making of altruism: branding and identity in egg donation websites in Spain	6
Vegetative value: promissory horizons of therapeutic innovation in the global circulation of ayahuasca	5
Sexual health as surplus: the marketization of PrEP in Taiwan	5
Beyond secrecy and openness: telling a relational story about children’s best interests in donor-conceived families	5
Device activism and material participation in healthcare: retracing forms of engagement in the #WeAreNotWaiting movement for open-source closed-loop systems in type 1 diabetes self-care	5
The life and death of confidentiality: a historical analysis of the flows of patient information	5
Fake eggs: from counter-qualification to popular certification in China’s food safety crisis	5
Ectogenesis, inequality, and coercion: a reproductive justice-informed analysis of the impact of artificial wombs	5
The Covid-19 caesura and the post-pandemic future	5
Allostatic load: historical origins, promises and costs of a recent biosocial approach	4
Genome editing: From bioethics to biopolitics	4
Legitimate suffering: a case of belonging and sickle cell trait in Brazil	4
Agri-food tech’s building block: narrating protein, agnostic of source, in the face of crisis	4

Pharmaceutical innovation and its crisis: drug markets, screening, and the dialectics of value	4
Analysing bio-art’s epistemic landscape: from metaphoric to post-metaphoric structure	4
Value regimes and pricing in the pharmaceutical industry: financial capital inflation (hepatitis C) versus innovation and production capital savings for malaria medicines	3
Living in the era of codes: a reflection on China’s health code system	3
Making it happen: data practices and the power of diplomacy among Danish organ transplant coordinators	3
The ongoing work of kinship among donor half-siblings in The Netherlands	3
Discipline for pleasure: a new governmentality of HIV prevention	3
Epigenetic citizenship and political claims-making: the ethics of molecularizing structural racism	3
Adjusting the analytical aperture: propositions for an integrated approach to the social study of reproductive technologies	3
“It’s harder for the likes of us”: racially minoritised stem cell donation as ethico-racial imperative	3
Post-identifiability in changing sociotechnological genomic data environments	2
Diversity via datafication? Digital patient records and citizenship for sexuality and gender diverse people	2
Figuring the ‘cynical scientist’ in British animal science: the politics of invisibility	2
Beyond controversies in child mental health: negotiating autism and ADHD diagnosis in France and Brazil	2
The politics of Danish IVF: reproducing the nation by making parents through selective reproductive technologies	2
Care during ART scale-up: surviving the HIV epidemic in Ethiopia	2
Race and Biomedicine Beyond the Lab: 21st Century Mobilisations of Genetics—Introduction to the Special Issue	2
The ‘new hysteria’?: wandering wombs, media representations and future imaginaries	2
Keeping race at bay: familial DNA research, the ‘Turkish Community,’ and the pragmatics of multiple collectives in investigative practice	2
Conceptualization of genotype–phenotype relationships and the assessment of risk in advertising of direct-to-consumer and preimplantation polygenic tests	2
The other face of medical globalization? Pharmaceutical data, prescribing trends, and the social localization of psychostimulants	2
Making epistemic goods compatible: knowledge-making practices in a lifestyle intervention RCT on mindfulness and compassion meditation	2
Epidemiologists’ ambivalence towards the epigenetics of social adversity	2
Molecular sovereignties: patients, genomes, and the enduring biocoloniality of intellectual property	2
When data drive health: an archaeology of medical records technology	2
Openness in donor conception families	2
Pigs, people and politics: the (re)drawing of Denmark’s biological, politico-geographical, and genomic ‘borders’	2
In whose pockets? How small Danish patient organisations balance legitimacy, representation and dependency in collaboration with public sector medical researchers and the life science industry	1
Emerging infrastructures: the politics of radium and the validation of radiotherapy in India’s first tertiary cancer hospital	1
Dr. Zahir’s dilemma: money and morals in India’s private medical networks	1
Anticipating and suspending: the chronopolitics of cryopreservation	1
Suspending life, controlling change: cryotechnology, genetic identity, and ecological separation	1
Entrepreneurial treatment activism for undone science: mannitol and Parkinson’s disease	1
Foetal programming meets human capital: biological plasticity, development, and the limits to the economization of life	1
Chemical species: the art and politics of living with(out) drugs after addiction	1
How opioids became “safe”: pharmaceutical splitting and the racial politics of opioid safety	1
Framing regenerative medicine: culturally specific stories of an emerging technoscience	1
Mapping ‘bio geo-body’ of Southeast Asia: strategic differentiation and identification of ethnic identity in Vietnam and Singapore	1
Primate nation: the (after)lives of iconic creatures in American space science	1
Cell freezing and the biology of inexorability: on cryoprotectants and chemical time	1
Accept no limits: biocontainment and the construction of a safer space for experimentation in xenobiology as a legacy of Asilomar	1
“It gives me time, but does it give me freedom?”: a contextual understanding of anticipatory decision-making in social egg freezing	1
Tissue culture and biological time: Alexis Carrel, Henri Bergson and the plasticity of living matter	1
Formatting patient knowledge and channelling participation: how patient organisations work under authoritarianism	1
It’s all about kids, kids, kids! Negotiating reproductive citizenship and patient-centred care in ‘factory IVF’	1
“Being useful, I think it's the result of a sick society”: Critical reflections on reproductive politics and markets by women freezing their eggs in Spain	1
Organ donation in principle and in practice: tensions and healthcare professionals’ troubled consciences	1
Donors we choose: race, nation and the biopolitics of (queer) assisted reproduction in Scandinavia	1
Population anxieties in constituting Nordic welfare state futures: affective biopolitics in the age of environmental crises	1